Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 10483
119th Congress(2025-2026)
Bone Marrow Radiation Shielding Act
Introduced
Introduced
Introduced in House on Sep 17, 2026
Overview
Text
Introduced in House 
Sep 17, 2026
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Sep 17, 2026)
Sep 17, 2026
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 10483 (Introduced-in-House)


119th CONGRESS
2d Session
H. R. 10483


To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability.

IN THE HOUSE OF REPRESENTATIVES

September 17, 2026

Mr. Bacon introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To direct the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs to seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment with respect to bone marrow radiation shielding for nuclear survivability.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Bone Marrow Radiation Shielding Act”.

SEC. 2. Independent assessment of bone marrow radiation shielding for nuclear survivability.

(a) Assessment required.—Not later than 30 days after the date of the enactment of this Act, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense, Policy and Programs shall seek to enter into an agreement with a University Affiliated Research Center affiliated with United States Strategic Command to conduct an independent scientific assessment on whether preserving the viability of bone marrow using partial body radiation shielding can improve the survivability of an individual exposed to gamma radiation as compared to an individual without such protection.

(b) Elements.—The assessment required under subsection (a) shall examine peer-reviewed scientific literature, laboratory studies and relevant experimental data to evaluate the comparative effectiveness of preserving bone marrow using partial body radiation shielding with respect to—

(1) the likelihood of developing Acute Radiation Syndrome;

(2) the severity of Acute Radiation Syndrome when it occurs; and

(3) overall mortality rates following gamma radiation exposure.

(c) Report.—Not later than 150 days after the date of the enactment of this Act, the Assistant Secretary shall submit to the Committees on Armed Services of the House of Representatives and the Senate a report on the assessment required under subsection (a) that includes the findings of such assessment.